117 related articles for article (PubMed ID: 8820565)
1. Clostridium difficile toxins attack Rho.
Wilkins TD; Lyerly DM
Trends Microbiol; 1996 Feb; 4(2):49-51. PubMed ID: 8820565
[No Abstract] [Full Text] [Related]
2. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
3. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
[TBL] [Abstract][Full Text] [Related]
5. Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins.
Just I; Hofmann F; Genth H; Gerhard R
Int J Med Microbiol; 2001 Sep; 291(4):243-50. PubMed ID: 11680784
[TBL] [Abstract][Full Text] [Related]
6. Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin.
Giry M; Popoff MR; von Eichel-Streiber C; Boquet P
Infect Immun; 1995 Oct; 63(10):4063-71. PubMed ID: 7558320
[TBL] [Abstract][Full Text] [Related]
7. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
Jank T; Aktories K
Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
[TBL] [Abstract][Full Text] [Related]
8. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital.
al-Barrak A; Embil J; Dyck B; Olekson K; Nicoll D; Alfa M; Kabani A
Can Commun Dis Rep; 1999 Apr; 25(7):65-9. PubMed ID: 10344088
[No Abstract] [Full Text] [Related]
9. Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression.
Dreikhausen U; Varga G; Hofmann F; Barth H; Aktories K; Resch K; Szamel M
Eur J Immunol; 2001 May; 31(5):1610-9. PubMed ID: 11465119
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
Zumbado-Salas R; Gamboa-Coronado Mdel M; RodrĂguez-Cavallini E; Chaves-Olarte E
Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol, it's not just for heart disease anymore.
Kerzmann A; Feig AL
ACS Chem Biol; 2006 Apr; 1(3):141-4. PubMed ID: 17163660
[TBL] [Abstract][Full Text] [Related]
12. Bacterial toxins and the Rho GTP-binding protein: what microbes teach us about cell regulation.
Fiorentini C; Gauthier M; Donelli G; Boquet P
Cell Death Differ; 1998 Sep; 5(9):720-8. PubMed ID: 10200530
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of enterotoxin producing Staphylococcus aureus in stools of patients with nosocomial diarrhea.
Flemming K; Ackermann G
Infection; 2007 Oct; 35(5):356-8. PubMed ID: 17721737
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of the Clostridium difficile toxins.
Thelestam M; Chaves-Olarte E
Curr Top Microbiol Immunol; 2000; 250():85-96. PubMed ID: 10981358
[No Abstract] [Full Text] [Related]
15. Activation of MMP-2 by Clostridium difficile toxin B in bovine smooth muscle cells.
Koike T; Kuzuya M; Asai T; Kanda S; Cheng XW; Watanabe K; Banno Y; Nozawa Y; Iguchi A
Biochem Biophys Res Commun; 2000 Oct; 277(1):43-6. PubMed ID: 11027636
[TBL] [Abstract][Full Text] [Related]
16. Hyperphosphorylation of calnexin, a chaperone protein, induced by Clostridium difficile cytotoxin.
Schué V; Green GA; Girardot R; Monteil H
Biochem Biophys Res Commun; 1994 Aug; 203(1):22-8. PubMed ID: 8074658
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics.
Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M
Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.
O'Connor D; Hynes P; Cormican M; Collins E; Corbett-Feeney G; Cassidy M
J Clin Microbiol; 2001 Aug; 39(8):2846-9. PubMed ID: 11474001
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital.
Martirosian G; Szczesny A; Cohen SH; Silva J
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):153-5. PubMed ID: 15964504
[TBL] [Abstract][Full Text] [Related]
20. What is the true burden of Clostridium difficile disease?
Wren MW; Coen PG; Shetty NP
J Hosp Infect; 2007 Oct; 67(2):196-7. PubMed ID: 17884251
[No Abstract] [Full Text] [Related]
[Next] [New Search]